Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Crossref DOI link: https://doi.org/10.3389/fonc.2018.00092
Published Online: 2018-03-29
Update policy: https://doi.org/10.3389/crossmark-policy
Suraweera, Amila
O’Byrne, Kenneth J.
Richard, Derek J.
Funding for this research was provided by:
National Health and Medical Research Council (1066550)
Cancer Council Queensland
Australian Research Council (DP 120103099)
License valid from 2018-03-29
